EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for SNYR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
NRX Pharmaceuticals, Inc. 0.0113
IGC Pharma, Inc. -0.0076
Vivos Therapeutics, Inc. -0.7424
NeOnc Technologies Holdings, Inc. -0.7158
BioVie, Inc. -0.7663